Cited 1 times in
인공혈액의 현재와 전망 : 적혈구 대용제제를 중심으로
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김종훈 | - |
dc.contributor.author | 이기영 | - |
dc.date.accessioned | 2015-04-24T16:25:48Z | - |
dc.date.available | 2015-04-24T16:25:48Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/103497 | - |
dc.description.abstract | Blood substitutes, especially red blood cell (RBC) substitutes, have been developed for the past five decades and have several advantages over allogenic packed RBCs, including a prolonged half-life, lack of a cross-matching requirement, and minimal infection risk or concerns about immunologic reactions. There are two main groups in RBC substitutes: perfluorochemicals and hemoglobin-based oxygen carriers (HBOCs). HBOCs are made of hemoglobins from:human, bovine or recombinant and undergo three modification types: chemical (intramolecular cross-linking, polymerization, conjugation to macromolecules and combination of several chemical modifications), genetic, or technological (microencapsulation). The types, side effects, current status of clinical trials, and the future of HBOCs are described in details | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 168~181 | - |
dc.language | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.publisher | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.relation.isPartOf | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | 인공혈액의 현재와 전망 : 적혈구 대용제제를 중심으로 | - |
dc.title.alternative | Current Status and Future of Artificial Blood- Focusing on Red Blood Cell Substitutes | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Anesthesiology (마취통증의학) | - |
dc.contributor.googleauthor | 김종훈 | - |
dc.contributor.googleauthor | 이기영 | - |
dc.identifier.doi | 10.5124/jkma.2009.52.2.168 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00930 | - |
dc.contributor.localId | A02695 | - |
dc.relation.journalcode | J01833 | - |
dc.identifier.eissn | 2093-5951 | - |
dc.subject.keyword | Blood substitute | - |
dc.subject.keyword | Red blood cell substitute | - |
dc.subject.keyword | Hemoglobin based oxygen carrier | - |
dc.contributor.alternativeName | Kim, Jong Hoon | - |
dc.contributor.alternativeName | Lee, Ki Young | - |
dc.contributor.affiliatedAuthor | Kim, Jong Hoon | - |
dc.contributor.affiliatedAuthor | Lee, Ki Young | - |
dc.citation.volume | 52 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 168 | - |
dc.citation.endPage | 181 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, Vol.52(2) : 168-181, 2009 | - |
dc.identifier.rimsid | 36043 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.